Dr. Filip Janku speaks with Cancer Network about a phase I clinical trial investigating the use of bacterial clostridium novyi-NT in solid tumors.
Filip Janku, MD, PhD
Advertisement
Articles by Filip Janku, MD, PhD
Advertisement
Latest Updated Articles
Bacterial Therapy May Be Promising in Cancer PatientsPublished: November 6th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
Future of PCI: PCI vs MRI surveillance
4
Novel TLR Coagonist Combo Shows Responses in Stage IV NSCLC
5
